Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2026-02-08 @ 2:45 PM
Study NCT ID:
NCT02062359
Status:
TERMINATED
Last Update Posted:
2016-06-24
First Post:
2014-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-02
Start Date Type:
None
Primary Completion Date:
2016-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-12
First Submit QC Date:
None
Study First Post Date:
2014-02-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-11
Results First Submit QC Date:
None
Results First Post Date:
2016-05-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-05-19
Last Update Post Date:
2016-06-24
Last Update Post Date Type:
ESTIMATED